Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Incipient enamel caries, commonly referred to as white spot lesions (WSLs), represent the earliest clinically detectable stage of dental caries, characterized by subsurface demineralization of the enamel (StatPearls, 2023). These lesions appear as chalky white, opaque areas on the tooth surface because the loss of mineral content increases the porosity of the enamel, which alters its light-scattering properties (Journal of Clinical and Experimental Dentistry, 2017). The pathology is driven by the metabolic activity of acidogenic bacteria, primarily Streptococcus mutans, which ferment dietary carbohydrates into organic acids that dissolve the hydroxyapatite mineral matrix (Nature Reviews Disease Primers, 2017). Unlike cavitated caries, incipient lesions maintain a relatively intact surface layer, making them amenable to non-invasive remineralization therapies (NIH, 2024). Management strategies focus on shifting the local environment from demineralization to remineralization using agents such as topical fluorides, which promote the formation of acid-resistant fluorapatite, or calcium-phosphate-based systems like CPP-ACP (StatPearls, 2023). If the demineralization process is not arrested or reversed, the structural integrity of the enamel eventually fails, leading to permanent cavitation and the need for restorative dental intervention.
Therapeutic agents for incipient caries primarily function by promoting the remineralization of the enamel subsurface through the delivery of calcium and phosphate ions, often enhanced by fluoride which catalyzes the formation of fluorapatite (StatPearls, 2023). Antimicrobial agents reduce the population of acid-producing bacteria, while resin infiltration techniques physically occlude the microporosities of the lesion to arrest the diffusion of acids and prevent further mineral loss (Journal of Clinical and Experimental Dentistry, 2017).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Incipient enamel caries (WSL).